Caraco Pharmaceutical


saw three of its plants raided by federal agents and its products seized after the

Food and Drug Administration

declared the company in violation of its "Good Manufacturing Practice requirements."

The Thursday raid was yet another indication that new FDA chief, Margaret "Peggy" Hamburg, appointed by President Obama, has taken to cracking the regulatory whip more vigorously than her recent predecessors.

TheStreet Recommends

In a press release, the FDA said it completed an investigation of the company's facilities in May. Caraco had already voluntarily submitted to a recall of some of its drugs in January.

The current action affects all 33 of Caraco's various product types, the agency said, adding that the seizure "may create a shortage of one product, choline magnesium trisalicylate oral tablets, which are commonly used as pain relievers."

Caraco's already beaten-down


-listed shares lost almost half their value Thursday, plunging, $1.85, or 44%, to $2.33, on 10-times the daily average volume.

Copyright 2009 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.